Bausch Health Companies Inc. (TSX:BHC)
7.07
+0.83 (13.30%)
Apr 17, 2025, 4:00 PM EDT
Bausch Health Companies Revenue
In the year 2024, Bausch Health Companies had annual revenue of $9.63B USD with 9.91% growth. Bausch Health Companies had revenue of $2.56B in the quarter ending December 31, 2024, with 6.27% growth.
Revenue
$9.63B
Revenue Growth
+9.91%
P/S Ratio
0.19
Revenue / Employee
$464.98K
Employees
20,700
Market Cap
2.61B CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Green Thumb Industries | 1.64B |
dentalcorp Holdings | 1.55B |
Sienna Senior Living | 893.16M |
Extendicare | 1.47B |
WELL Health Technologies | 919.69M |
Cronos Group | 169.23M |
Trulieve Cannabis | 1.71B |
Curaleaf Holdings | 1.93B |
Bausch Health Companies News
- 1 day ago - U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich - Accesswire
- 3 days ago - Bausch Health Companies Inc (BHC) Adopts Shareholder Rights Plan | BHC stock news - GuruFocus
- 4 days ago - Bausch Health Announces Adoption of Shareholder Rights Plan - Accesswire
- 7 days ago - Bausch Health Companies Inc (BHC) Launches 2025 ASPIRE HIGHER Scholarship Program | BHC stock news - GuruFocus
- 8 days ago - Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program - Accesswire
- 9 days ago - Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris - Accesswire
- 13 days ago - Bausch Health: Repositioning Aplezin As First Oral Monotherapy For TRD A $3 Billion Opportunity - Seeking Alpha
- 16 days ago - Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month - Accesswire